登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 6658 条符合本次的查询结果， 用时 6.5540422 秒

3321. Impact of the Combined Immunosuppressive Therapy on Different Mortality Score Groups in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease and the Problem of Sample Splitting.

作者: Daisuke Waki.;Keisuke Nishimura.
来源: Chest. 2021年159卷2期882-883页

3322. Response.

作者: Jose Iglesias.
来源: Chest. 2021年159卷2期882页

3323. HAT Therapy: Really Beneficial?

作者: Hiroshi Shiba.;Saburo Minami.;Atsushi Shiraishi.
来源: Chest. 2021年159卷2期881页

3324. Response.

作者: Jose Iglesias.; .
来源: Chest. 2021年159卷2期880-881页

3325. Vitamin C in Sepsis: The Road Ahead.

作者: Prerna Garg.;Praveen Tirlangi.;Umang Arora.;Manish Soneja.
来源: Chest. 2021年159卷2期879-880页

3326. Response.

作者: Seth R Bauer.;Xiaozhen Han.;Xiao-Feng Wang.;Anita J Reddy.
来源: Chest. 2021年159卷2期878-879页

3327. Striving to Comply With the Sepsis Quality Measure: Are the Challenges Worth the Rewards?

作者: Lavi Oud.
来源: Chest. 2021年159卷2期877-878页

3328. Regional Airway Heterogeneity in Asthma: Histopathology, MRI, and CT Imaging.

作者: Rachel L Eddy.;Grace Parraga.
来源: Chest. 2021年159卷2期876-877页

3329. Into Thin Air: A Step Forward to Counsel Patients With Pulmonary Hypertension Travelling to High Altitude.

作者: Thomas Brack.
来源: Chest. 2021年159卷2期484-485页

3330. Performance Under Pressure: The Relevance of Pulmonary Vascular Response to Exercise Challenge in Scleroderma.

作者: Silvia Ulrich.;Stephen C Mathai.
来源: Chest. 2021年159卷2期481-483页

3331. Our Pipeline at Risk?: Burnout in Pulmonary and Critical Care Fellowship Training.

作者: Janae K Heath.;Meeta Prasad Kerlin.
来源: Chest. 2021年159卷2期479-480页

3332. Emerging Role of Remote Patient Monitoring in Pulmonary Care: Telemedicine to Smart Phone.

作者: Neeraj R Desai.;Edward J Diamond.
来源: Chest. 2021年159卷2期477-478页

3333. Antacid Therapy in Idiopathic Pulmonary Fibrosis: A Swinging Pendulum.

作者: Lee M Fidler.;Kerri A Johannson.
来源: Chest. 2021年159卷2期475-476页

3334. Vascular Pruning: A Sign of Early Pulmonary Vascular Disease or a Surrogate Marker of Interstitial Lung Abnormalities?

作者: Andrea S Oh.
来源: Chest. 2021年159卷2期473-474页

3335. Looking to the Past, Learning From the Present, and Preparing for the Future: Toward Understanding Critical Care Strain During a Global Pandemic.

作者: Kelly C Vranas.;Meeta Prasad Kerlin.
来源: Chest. 2021年159卷2期469-470页

3336. Eccentric Exercise in COPD: Take It or Leave It?

作者: Joana Cruz.;Chris Burtin.
来源: Chest. 2021年159卷2期467-468页

3337. Are Guidelines Fueling Inequity? A Call to Action for Guideline Developers and Their Panelists.

作者: Eddy Lang.;Suzana Alves da Silva.;Nav Persaud.
来源: Chest. 2021年159卷2期465-466页

3338. You Gotta Make Me See, What Does It Mean to Have an MIC?

作者: David E Griffith.;Kevin L Winthrop.
来源: Chest. 2021年159卷2期462-464页

3339. Time for a Paradigm Shift.

作者: Hitasha Rupani.
来源: Chest. 2021年159卷2期459-461页

3340. Relationship Between Obesity and Ventilator-Associated Pneumonia: A Post Hoc Analysis of the NUTRIREA2 Trial.

作者: Saad Nseir.;Amélie Le Gouge.;Olivier Pouly.;Jean-Baptiste Lascarrou.;Jean-Claude Lacherade.;Jean-Paul Mira.;Emmanuelle Mercier.;Pierre-Louis Declercq.;Michel Sirodot.;Gaël Piton.;François Tinturier.;Elisabeth Coupez.;Stéphane Gaudry.;Michel Djibré.;Didier Thevenin.;Malika Balduyck.;Jean Reignier.; .
来源: Chest. 2021年159卷6期2309-2317页
Patients with obesity are at higher risk for community-acquired and nosocomial infections. However, no study has specifically evaluated the relationship between obesity and ventilator-associated pneumonia (VAP).
共有 6658 条符合本次的查询结果， 用时 6.5540422 秒